A series of previous studies showed that miR-16 enhanced cell apoptosis by targeting the oncogene Bcl2 in hepatic stellate cells [11], and miR-16 acted as putative tumor suppressor by targeting VEGF-A in multiple myeloma [23]. Here, VEGFA is linked to plasma cell myeloma.